Spegra™ (30 tabs) is a licensed generic of Descovy® + Tivicay® (Tenofovir Alafenamide / Emtricitabine + Dolutegravir) which are U.S. FDA approved prescription HIV medicines that are used in combination as a complete treatment regimen for HIV-1. This three-drug combination will soon be the new WHO first line recommended treatment for HIV-1. The recommendation is based on Tenofovir Alafenamide’s improved renal and bone safety, as well as Dolutegravir’s improved tolerability, higher antiretroviral efficacy, lower rates of treatment discontinuation, a higher genetic barrier to resistance and fewer drug interactions than other ARV drugs. This treatment is indicated in adult and pediatric patients weighing at least 88 pounds (40 kg).
- Spegra™ may help decrease the amount of HIV in your body so your immune system can work better
- Spegra™ may lower your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life
Active Ingredients : Tenofovir Alafenamide 25 mg / Emtricitabine 200 mg + Dolutegravir 50 mg
Produced by Emcure Pharmaceuticals Ltd. (US FDA cGMP certified manufacturer)